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TO THE EDITOR
Nestin is a class VI intermediate fila-
ment protein that was first described as
a neural stem cell marker (Lendahl
et al., 1990). It is expressed throughout
the dermis in the early embryo and in
hair follicles after birth (Sellheyer
and Krahl, 2010). Nestin-positive hair
follicle cells located above the follicle
bulge region can differentiate into
various cell types during wound
healing (Amoh et al., 2009).
Nestin expression has also been
reported in various neoplasms. Nestin
knockdown inhibits migration, invasion,
and metastasis of pancreatic cancer
cells (Matsuda et al., 2011), suggesting
that the protein could be a novel
therapeutic target for tumors. In
melanoma, nestin overexpression has
been observed in advanced stages of
the disease (Brychtova et al., 2007), in
the invading front (Piras et al., 2010)
and at sites of melanoma metastases
(Klein et al., 2007). The number of
circulating nestin-positive melanoma
cells in the peripheral blood of patients
correlates with a poor prognosis (Fusi
et al., 2011). Therefore, in this study, we
used a gene silencing strategy to
investigate the potential effectiveness of
a nestin-targeting therapy in malignant
melanomas.
Nestin was found to be strongly
expressed in A375 and MeWo mela-
noma cells, but weakly expressed in
G361 cells (Supplementary Figure S1a,
b, c online and Supplementary Material
online). We first suppressed nestin
expression in A375 cells using short
hairpin RNA (shRNA) (Matsuda et al.,
2011). Nestin expression was lower in
cells transfected with nestin shRNA (Sh)
than in cells transfected with a
scrambled sequence shRNA (Sc) and
nontreated (wild) cells (Supplementary
Figure S1d and e online), confirming the
efficiency of the knockdown. Control
and nestin shRNA–transfected cells
exhibited similar morphology (Supple-
mentary Figure S2a online), whereas
F-actin polymerization was increased
in the cytoplasm of Sh cells compared
with Sc and wild cells (Supplementary
Figure S2c online, arrows), which was
similar to that observed in pancreatic
cancer cells (Matsuda et al., 2011).
Super-high-resolution images clearly
revealed the formation of F-actin fibers
in Sh cells (Supplementary Figure S2d
online, arrows). Nestin and F-actin
colocalized to the periphery of Sc cells
(Supplementary Figure S2d online,
arrowheads), but not in Sh cells. The
colocalization of nestin and F-actin
observed in this study suggests that
nestin regulates F-actin organization in
melanoma cells in a manner similar to
synemin, an intermediate filament pro-
tein, which was reported to modulate
actin dynamics (Pan et al., 2008).
The growth of Sh cells was lower than
that of Sc cells, as indicated by manual
counting of cell number (Figure 1a). A
WST-8 assay with Sh cells confirmed
these results (Figure 1b). Nestin has
been reported to regulate cell prolifera-
tion through the mitogen-activated pro-
tein kinase (MAPK) signaling pathway
(Johannessen et al., 2009; Xue and
Yuan, 2010); therefore, we analyzed
alterations of MAPK using Phospho-
MAPK Arrays. Phosphorylated AKT
was the only protein affected by nestin
silencing; no inhibitory effects were
observed for ERK, p38, JNK, or CREB.
Decreased phosphorylation of AKT in
Sh cells was confirmed by western
blotting (Figure 1c). This finding suggests
that AKT activation is important for
nestin function.
The effect of nestin silencing on
melanoma cell migration and invasion
was next analyzed using a modified
Boyden chamber assay. The migration
and invasion of Sh cells into the
matrigel layer was less than that of Sc
cells (Figure 1d and e). Next, we
analyzed the effect of nestin silencing
using siRNA targeting nestin (siA;
Supplementary Figure S1f online).
Knockdown of nestin with siRNA in
A375 cells also suppressed cell growth
Abbreviations: F-actin, filamentous-actin; MAPK, mitogen-activated protein kinase; Sc, scrambled
sequence shRNA; Sh, nestin shRNA; shRNA, short hairpin RNA; siRNA, small interfering RNA
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(Figure 1f), migration (Figure 1g), and
invasion (Figure 1h).
We performed a sphere-formation
assay to determine in vitro tumorigeni-
city of cells after treatment with
nestin shRNA (Santini et al., 2012).
The number of spheres in Sh cells was
lower than that in Sc and wild cells
(Figure 2a (arrows) and b). The spheres
in A375 cells expressed nestin protein
(Figure 2c, right panel; green fluore-
scence) and higher levels of nestin
mRNA than non-sphere cells
(Figure 2d).
In a xenotransplantation experiment
using nude mice, subcutaneous
tumors originating from Sh cells were
smaller and weighed significantly
less (Figure 2e) compared with those
originating from Sc cells (Po0.05).
Moreover, after tail vein injection of
these cells into nude mice, liver meta-
stases were observed in Sc mice, but not
in Sh mice (Figure 2f, upper panels;
arrows). Immunohistochemical staining
of liver sections using an anti-HLA
antibody showed that the liver area
occupied by the tumor was less in the
Sh group than in the Sc group (Figure 2f,
lower panels, arrows; and Figure 2g).
We also examined the effects of
reduced nestin expression on cell pro-
liferation, migration, and invasion using
nestin-targeting siRNAs (siA and siB) in
melanoma cells that express different
levels of nestin (Supplementary Figure
S3a online). These siRNAs reduced the
expression of nestin in MeWo cells,
which strongly express nestin mRNA,
but did not reduce the expression in
G361 cells (Supplementary Figure S3a
online). The effect of nestin siRNA
on cell growth was more apparent in
MeWo cells compared with the other
cell types (Supplementary Figure S3b
online). In addition, cell movement,
migration, and invasion were significantly
inhibited in MeWo cells (Supple-
mentary Figure S3c and d online), but
not in G361 cells (Supplementary Figure
S3c and e online), after treatment with
nestin siRNA. However, these findings
do not eliminate the possibility that
decreased proliferative abilities have an
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Figure 1. Cell growth and motility in nestin shRNA or nestin siRNA–transfected A375 human melanoma cells. (a) Manual cell count growth assay and
(b) WST-8 cell growth assay of wild-type (Wild), scrambled sequence RNA–transfected (Sc), and nestin shRNA–transfected (Sh) A375 cells. (c) Western blot
of phosphorylated AKT, total AKT, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH). (d) Boyden chamber assay for cell migration, and (e) cell invasion
through matrigel. Bar¼ 100mm. (f) WST-8 cell growth assay of wild, negative control siRNA–transfected (siN), and nestin siRNA–transfected (siA) A375 cells.
(g) Cell migration and (h) invasion in nestin siRNA–transfected A375 cells. *Po0.05 and **Po0.01 vs. wild, Sc, or siN cells.
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effect on metastasis and sphere forma-
tion of melanoma cells.
We next tested the effects of nestin
siRNA on the cell behavior of non-
tumorigenic cells. Human epidermal
melanocytes (HEMn-LP) expressed low
levels of nestin (Supplementary Figure
S3a online). Moreover, nestin siRNA
transfection of these cells did not
decrease nestin mRNA levels and had
no effect on cell growth and motility
(Supplementary Figure S4 online).
Tumor stem cells that possess self-
renewal ability and multilineage poten-
tial have been considered to have
important roles in tumor development
(Reya et al., 2001). Melanoma stem
cells seem to possess a strong ability to
efflux Hoechst33342 dye, which is a
characteristic of stem cells, and these
cells express nestin (Grichnik et al.,
2006). Melanoma spheroid cells have
been reported to possess a high number
of tumor stem–like cells (Fang et al.,
2005). We found that sphere-forming
melanoma cells express high levels of
nestin, and that knockdown of nestin
suppresses the sphere-forming ability,
suggesting a relationship between
nestin expression and melanoma
stem–like cell functions.
In conclusion, we have found
that reducing the expression of nestin
in melanoma cells decreases the cell
growth, migration, invasion, and sphere-
forming ability in vitro and tumor
growth and metastasis in vivo, in part,
through alteration of the expression
pattern of F-actin and regulation of the
MAPK pathway. Therefore, nestin may
be a therapeutic candidate for treating
malignant melanoma.
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through the tail vein. Macroscopic images (upper panels) and immunohistochemistry of HLA in the liver
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TO THE EDITOR
There is growing evidence for func-
tional interactions between nociceptive
nerve endings and non-neuronal cells
modulating sensory function in health
and disease. In the skin, non-neuronal
cells like keratinocytes actively partici-
pate in nociceptor sensitization and thus
in encoding of noxious stimuli (Lumpkin
and Caterina, 2007; Gold and Gebhart,
2010). In vivo approaches for live-cell
imaging of the interplay of sensory
terminals and surrounding cells are
hampered by the small diameter of the
endings and the difficult experimental
accessibility. Moreover, selectively
stimulating one type of cell while
recording responses from both is
challenging. Our goal was therefore to
establish an in vitro model that would
allow studying potential functional
interactions between nociceptive
terminals and keratinocytes.
To this end, we developed a cocul-
ture model of sensory endings and
keratinocytes in a compartmented Cam-
penot chamber (Figure 1a; Campenot
et al., 2009; Roggenkamp et al., 2012).
Compartmented chambers for coculture
(Chateau et al., 2007; Roggenkamp
et al., 2012) have the advantage of a
spatial segregation of neurites (Ns) from
their somata (Figure 1a) compared with
a coculture in one compartment
(Ulmann et al., 2009; Pereira et al.,
2010a,b). Moreover, in the Campenot
chamber, fluid isolation between the
compartments allows different culture
media and factors for neuronal
somata in one compartment and
for Ns and keratinocytes in the other,
mimicking the in vivo structural and
environmental conditions. In our
experiments, isolated somata of
porcine dorsal root ganglion neurons
(Obreja et al., 2008) were grown in
the central compartment; Ns outgrown
into the lateral compartments served as
a model for sensory endings. These
Ns were cocultured with primary
isolated porcine keratinocytes (see
Supplementary information).
Using this approach, we obtained
areas of confluent keratinocytes in spa-
tial contact with sensory Ns (Figure 1b
and c). By using atomic force micro-
scopy (AFM), we visualized nanoscaled
surface topographies of adjacent Ns and
keratinocytes (Figure 1d). In the past,
AFM had been established as a tool for
the characterization of cell–cell contacts
comprising also the desmosomal junc-
tions between the keratinocytes (Fung
et al., 2010). In comparison, our images
suggest cell–cell contacts not only
between keratinocytes but also possibly
between Ns and keratinocytes. For func-
tional investigations, we implemented
live-cell imaging combined with chemi-
cal or mechanical stimulation, allowing
selective activation of one cell type
while recording responses simulta-
neously from both types. Responses to
these stimuli were visualized using the
non-ratiometric calcium dye Fluo8 acet-
oxymethyl ester. To activate only Ns, a
membrane-depolarizing concentration
of KCl was added to the somata contain-
ing central compartment. The induced
depolarization is transmitted along the
Ns into the lateral compartment,
indicated by a calcium response
(Supplementary Figure S1a online). For
specific activation of nociceptive Ns,
capsaicin was added to the lateral com-
partment (Supplementary Figure S1b
online; Caterina et al., 2007).
In coculture of Ns and keratinocytes
in the lateral compartment, we observed
an interaction between both cell types.
In the experiment shown in Figure 2a–d,
KCl was first applied to the central
compartment. After an immediateAbbreviations: AFM, atomic force microscopy; N, neurite
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